Difference between revisions of "CD117"

Jump to navigation Jump to search
982 bytes added ,  16:31, 13 January 2022
no edit summary
(Created page with "'''CD117''' is common immunostain. ==Positive== *Gastrointestinal stromal tumour. *Seminoma. *Renal oncocytoma. *Chromophobe renal cell carcinoma. *Ren...")
 
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''CD117''' is common [[immunostain]].  
'''CD117''' is common [[immunostain]].  
==Normal tissue positive==
*Mast cells.<ref name=pmid16082245>{{cite journal |authors=Miettinen M, Lasota J |title=KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation |journal=Appl Immunohistochem Mol Morphol |volume=13 |issue=3 |pages=205–20 |date=September 2005 |pmid=16082245 |doi=10.1097/01.pai.0000173054.83414.22 |url=}}</ref>
*Cajal cells.<ref name=pmid16082245/>
*Germ cells.<ref name=pmid16082245/>
*Melanocytes.<ref name=pmid16082245/>


==Positive==
==Positive==
*[[Gastrointestinal stromal tumour]].
*[[Gastrointestinal stromal tumour]].
*[[Seminoma]].
*[[Seminoma]].<ref name=pmid24832161>{{cite journal |author=Ulbright TM, Tickoo SK, Berney DM, Srigley JR |title=Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the international society of urological pathology consensus conference |journal=Am. J. Surg. Pathol. |volume=38 |issue=8 |pages=e50–9 |year=2014 |month=August |pmid=24832161 |doi=10.1097/PAS.0000000000000233 |url=}}</ref>
*[[Renal oncocytoma]].
*[[Renal oncocytoma]].
*[[Chromophobe renal cell carcinoma]].
*[[Chromophobe renal cell carcinoma]].
*[[Renal hybrid oncocytic/chromophobe tumour]].
*[[Renal hybrid oncocytic/chromophobe tumour]].
*[[Adenoid cystic carcinoma]].


==See also==
==See also==
48,466

edits

Navigation menu